Michael J. Sernyak, MD

Article

Race and Long-Acting Antipsychotic Prescription at a Community Mental Health Center: A Retrospective Chart Review

April 15, 2012

Educational Activity

Identifying Metabolic Risks With Antipsychotics and Monitoring and Management Strategies

July 16, 2007

Article

Implementation of Monitoring and Management Guidelines for Second-Generation Antipsychotics

April 16, 2007

Original Research

Undiagnosed Hyperglycemia in Patients Treated With Atypical Antipsychotics

November 15, 2005

Original Research

Clinicians' Reasons for Antipsychotic Coprescribing

December 15, 2004

Article

Antipsychotic Drugs, Insulin Resistance, Hyperglycemia, and Diabetes Mellitus

May 1, 2004

Article

Conclusions: Antipsychotic-Induced Weight Gain and Metabolic Abnormalities

May 1, 2004

Article

Epidemiology of Cardiovascular Disease and Major Metabolic Risk Factors

May 1, 2004

Article

The Impact of Atypical Antipsychotics on Weight Gain

May 1, 2004

Article

Monitoring Metabolic Side Effects

May 1, 2004

Article

Schizophrenia, Metabolic Disorders, and Cardiovascular Disease

May 1, 2004

Article

Treatment Recommendations for Psychiatrists

May 1, 2004